- Report
- April 2025
- 147 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- June 2025
- 226 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- January 2026
- 184 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2024
- 330 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- November 2024
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,281USD£3,144GBP
Source Plasma is a type of blood product derived from the plasma of healthy donors. It is used in the manufacture of a variety of therapeutic products, such as clotting factors, albumin, and immunoglobulins. It is also used in the production of vaccines and other biopharmaceuticals. In the blood banking industry, source plasma is collected from donors and then processed and tested for safety before being used in the manufacture of therapeutic products.
Source plasma is a valuable resource for the blood banking industry, as it is used to produce a variety of therapeutic products. It is also used in the production of vaccines and other biopharmaceuticals.
Some companies in the source plasma market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more
